PRESS RELEASE published on 11/17/2025 at 07:00, 8 months 24 days ago Inside Information / Other news releases Innate Pharma to present at Jefferies Global Healthcare Conference on November 17, 2025. A global biotechnology company focusing on cancer immunotherapies Biotechnology Immunotherapy Cancer Innate Pharma Jefferies Global Healthcare Conference
BRIEF published on 10/14/2025 at 07:05, 9 months 28 days ago Innate Pharma met en avant lacutamab lors d'un événement analystes et investisseurs Investisseurs Essai Clinique Innate Pharma Lacutamab Syndrome De Sézary
BRIEF published on 10/14/2025 at 07:05, 9 months 28 days ago Innate Pharma Highlights Lacutamab at Analyst and Investor Event Investors Clinical Trial Innate Pharma Lacutamab Sézary Syndrome
PRESS RELEASE published on 10/14/2025 at 07:00, 9 months 28 days ago Inside Information / Other news releases Innate Pharma to host analyst and investor event on Lacutamab on October 28, 2025. Event includes clinical perspectives, market outlook, and updates on Phase 3 trial and regulatory pathway for lacutamab Phase 3 Trial Investor Event Regulatory Pathway Innate Pharma Lacutamab
PRESS RELEASE published on 10/14/2025 at 07:00, 9 months 28 days ago Informations privilégiées / Autres communiqués Innate Pharma organise un événement analystes et investisseurs dédié à Lacutamab le 28 octobre 2025, mettant en lumière les perspectives cliniques et commerciales du produit Investisseurs Événement Innate Pharma Analystes Lacutamab
PRESS RELEASE published on 09/22/2025 at 13:41, 10 months 18 days ago Informations privilégiées / Communiqué sur comptes, résultats
PRESS RELEASE published on 09/17/2025 at 07:00, 10 months 24 days ago Informations privilégiées / Communiqué sur comptes, résultats
BRIEF published on 09/10/2025 at 10:35, 11 months ago Innate Pharma Announces 2025 Half-Year Results Conference Call Financial Results Conference Call Immunotherapy Innate Pharma Biopharmaceutical Partnerships
BRIEF published on 09/10/2025 at 10:35, 11 months ago Innate Pharma Annonce une Conférence Téléphonique pour ses Résultats Semestriels 2025 Résultats Financiers Immunothérapie Conférence Téléphonique Partenariats Biopharmaceutiques Innate Pharma
PRESS RELEASE published on 09/10/2025 at 10:30, 11 months ago Inside Information / Other news releases Innate Pharma schedules conference call and webcast for first half 2025 financial results and business update. Details for participation available on the company's website Financial Results Conference Call Business Update Webcast Innate Pharma
Published on 08/11/2026 at 07:00, 43 minutes ago Alaska Energy Metals Announces Closing of Shares for Debt Settlement
Published on 08/11/2026 at 00:40, 7 hours 3 minutes ago CORRECTION FROM SOURCE: Fermi Announces Binding Lease Agreement with TensorWave
Published on 08/11/2026 at 00:25, 7 hours 18 minutes ago Empress Reports 2026 Second Quarter Financial Results
Published on 08/10/2026 at 23:35, 8 hours 8 minutes ago NioCorp Project to Expand Production to 8 Made-in-USA Critical Minerals Over a 40-Year Mine Life with an Estimated $4.1 Billion Pre-Tax NPV8%
Published on 08/10/2026 at 23:30, 8 hours 13 minutes ago Condor and Element79 Agree on Restructured Terms for Lucero Project
Published on 08/11/2026 at 07:30, 13 minutes ago STS Group AG's first half of 2026 lays a strong foundation for meeting its full-year targets
Published on 08/11/2026 at 07:30, 13 minutes ago Dermapharm Holding SE reports profitable growth in H1 2026 and confirms guidance
Published on 08/11/2026 at 07:30, 13 minutes ago Salzgitter Group reports encouraging first half of 2026
Published on 08/11/2026 at 07:01, 42 minutes ago NORMA Group delivers significantly higher profitability in the second quarter of 2026; Industry Applications continues to grow
Published on 08/11/2026 at 07:00, 43 minutes ago Infracore SA discloses information on stabilization purchases
Published on 08/10/2026 at 18:00, 13 hours 43 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 13 hours 43 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 13 hours 58 minutes ago Déclaration hebdomadaire de rachat d'actions
Published on 08/10/2026 at 11:53, 19 hours 49 minutes ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
